Patents by Inventor Delvin R. Knight

Delvin R. Knight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment with selective EP4 receptor agonists
    Patent number: 7414071
    Abstract: The present invention provides a method of treating hypertension, liver failure, loss of patency of ductus arteriosus, glaucoma or ocular hypertension in a patient, comprising administering to the patient a therapeutically effective amount of a selective EP4 receptor agonist of Formula I or a prodrug thereof, a pharmaceutically acceptable salt of the selective EP4 receptor agonist or prodrug or a stereoisomer or diastereomeric mixture of the EP4 receptor agonist, prodrug or salt, wherein the variables X, Z, Q, , and R2 are as defined in the specification.
    Type: Grant
    Filed: March 11, 2003
    Date of Patent: August 19, 2008
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Delvin R. Knight, Jr.
  • Methods of treatment with selective EP4 receptor agonists
    Publication number: 20030207925
    Abstract: The present invention provides a method of treating hypertension, liver failure, loss of patency of ductus arteriosus, glaucoma or ocular hypertension in a patient, comprising administering to the patient a therapeutically effective amount of a selective EP4 receptor agonist of Formula I 1
    Type: Application
    Filed: March 11, 2003
    Publication date: November 6, 2003
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Delvin R. Knight
  • Method of reducing tissue damage associated with non-cardiac ischemia
    Patent number: 6127367
    Abstract: A method of preventing non-cardiac tissue damage resulting from ischemia, comprising administering to a patient in need of such treatment an effective amount of an aldose reductase inhibitor.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: October 3, 2000
    Assignee: Pfizer, Inc.
    Inventors: Thomas A. Beyer, Delvin R. Knight, Jr., Banavara L. Mylari, Peter J. Oates, E. Roy Pettipher, W. Ross Tracey
  • Method of reducing tissue damage associated with ischemia
    Patent number: 5932581
    Abstract: A method of preventing tissue damage resulting from ischemia, comprising administering to a patient in need of such treatment an effective amount of a sorbitol dehydrogenase inhibitor.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: August 3, 1999
    Assignee: Pfizer Inc.
    Inventors: Thomas A. Beyer, Delvin R. Knight, Jr., Banavara L. Mylari, Peter J. Oates, E. Roy Pettipher, W. Ross Tracey